Cellebrite DI Ltd. (CLBT) — Analyst outlook / Analyst consensus target is. Based on 8 analyst ratings, the consensus is bullish — 8 Buy.
The consensus price target is $20.67 (low: $18.00, high: $23.00), representing an upside of 74.3% from the current price $11.86.
Analysts estimate Earnings Per Share (EPS) of $-1.29 and revenue of $0.40B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-1.35 vs est $-1.29 (missed -4.3%). 2025: actual $0.32 vs est $0.33 (missed -3.2%). Analyst accuracy: 96%.
CLBT Stock — 12-Month Price Forecast
$20.67
▲ +74.28% Upside
Average Price Target
Based on 8 Wall Street analysts offering 12-month price targets for Cellebrite DI Ltd., the average price target is $20.67, with a high forecast of $23.00, and a low forecast of $18.00.
The average price target represents a +74.28% change from the last price of $11.86.
Highest Price Target
$23.00
Average Price Target
$20.67
Lowest Price Target
$18.00
CLBT Analyst Ratings
Buy
Based on 8 analysts giving stock ratings to Cellebrite DI Ltd. in the past 3 months
EPS Estimates — CLBT
96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$1.35
vs Est –$1.29
▼ 4.1% off
2025
Actual $0.32
vs Est $0.33
▼ 3.3% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.
Revenue Estimates — CLBT
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.401B
vs Est $0.399B
▲ 0.5% off
2025
Actual $0.476B
vs Est $0.473B
▲ 0.6% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
